JF Zagury - US Patent 7,892,558, 2011 - Google Patents ... Finally, a subject of the present Application is a process for activeimmunization of patients ... 2 show the results of protection in vivo of the immunizations described in Experiments 1 ... SEQ ID NO 1 <211> LENGTH: 16 <212> TYPE: PRT <213> ORGANISM: Artificial <220> FEATURE ... Related articles - All 4 versions
[HTML] from ukpmc.ac.ukK Palucka, H Ueno, J Fay… - Journal of internal …, 2011 - Wiley Online Library ...Activeimmunization has been a successful strategy for the prevention of infectious diseases [15]. One example showing great promise with regard to cancer is the prevention of HPV-positive cervical cancer by vaccinating with a recombinant viral capsid protein [16]. ... Cited by 10 - Related articles - All 4 versions
J Zagury - US Patent App. 13/004,526, 2011 - Google Patents ... [0055] Finally, a subject of the present Application is a process for activeimmunization of patients ... they recognize only the cytokine the sequence of which was used for the immunization. ... ID NO 1 <2ll> LENGTH: 16 <2l2> TYPE: PRT <2l3> ORGANISM: Artificial <220> FEATURE ...
F Zheng… - Future, 2011 - Future Science ...activeimmunization (vaccine) [12–14] or passive immunity (monoclonal antibody produced in another host) [15,16]. The blocking action could also be implemented by administration of an appropriately designed enzyme [1,17], or a catalytic antibody (regarded as an artificial... Related articles - All 3 versions
[PDF] from mdpi.comSH Pincus, JE Smallshaw, K Song, J Berry… - Toxins, 2011 - mdpi.com ... This may include supplemental oxygen, continuous positive airway pressure breathing, and artificial ventilation. ... Both a vaccine for activeimmunization [6,49–52] and antibodies for passive immunization [64–66] are under development. ...
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
